drugset
Drugs / Autologous AdE1- Latent Membrane Protein CTLs
last change May 2012 re-read 3 minutes ago

Autologous AdE1- Latent Membrane Protein CTLs

Cell therapy

Developed for
lymphoma
Investigated by
Australian Department of Industry, Tourism and Resources · British Society for Haematology · National Health and Medical Research Council, Australia · Queensland Institute of Medical Research · The Atlantic Philanthropies

Trials 1

today NCT00779337 · Ph 1
2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00779337 Oct 2008 → Jan 2012 lymphoma Queensland Institute of Medical Research Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Autologous AdE1- Latent Membrane Protein CTLs ClinicalTrials.gov intervention name — accepted as the source's own label NCT00779337 ↗
Action Deplete “with the aim of killing the lymphoma cells” NCT00779337 ↗
Modality Cell therapy “therapy derived from a person's Killer T cells” NCT00779337 ↗
Route Intravenous “given intravenously” NCT00779337 ↗